Cargando…
Genome-wide association study identifies zonisamide responsive gene in Parkinson’s disease patients
Long-term treatment of Parkinson’s disease (PD) by levodopa leads to motor complication “wearing-off”. Zonisamide is a nondopaminergic antiparkinsonian drug that can improve “wearing-off” although response to the treatment varies between individuals. To clarify the genetic basis of zonisamide respon...
| Autores principales: | , , , , , |
|---|---|
| Formato: | Online Artículo Texto |
| Lenguaje: | English |
| Publicado: |
Springer Singapore
2020
|
| Materias: | |
| Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8075945/ https://www.ncbi.nlm.nih.gov/pubmed/32355309 http://dx.doi.org/10.1038/s10038-020-0760-8 |